Benefit of phosphodiesterase 4 inhibitors as supplemental therapy after lung transplantation concerning their antiproliferative effects: An experimental study using a heterotopic rodent model

Transplantation

Volumn 74, Issue 3, 2002, Pages 326-334

  Schade, Ina ^a   Roth Eichhorn, Sylke ^a   Kasper, Michael ^a   Kuss, Hildegard ^a   Plötze, Katrin ^a   Funk, Richard H W ^a   Schüler, Stephan ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CILOMILAST; CYCLOSPORIN A; IMMUNOMODULATING AGENT; PHOSPHODIESTERASE IV INHIBITOR; ROFLUMILAST; ROLIPRAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EXPERIMENTAL MODEL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG TRANSPLANTATION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; RODENT; TRACHEA MUCOSA;

EID: 0036678722     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200208150-00007     Document Type: Article

References (36)

1. The Registry of the International Society for Heart and Lung Transplantation: Seventeenth Official Report-2000
2. Constrictive (obliterative) bronchiolitis: Diagnosis, etiology, and a critical review of the literature
3. Actuarial survival of heartlung and bilateral sequential lung transplant recipients with obliterative bronchiolitis
4. Bronchiolitis obliterans: Pathogenesis, prevention, and management
5. PDE isoenzymes as targets for antiasthma drugs
6. Selective phosphodiesterase inhibitors for the treatment of bronchial asthma and chronic obstructive pulmonary disease
7. Phosphodiesterase activity in neutrophils from horses with chronic obstructive pulmonary disease
8. Phosphodiesterase (PDE)4 inhibitors: Anti-inflammatory drugs of the future?
9. Phosphodiesterase isoenzymes, molecular targets for novel antiasthma agents
10. Cyclic nucleotide phosphodiesterase (PDE) inhibitors and immunomodulation
11. Phosphodiesterases: The journey towards therapeutics
12. Phosphodiesterase type IV inhibitors
13. Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways
14. Cytomegalovirus infection enhances experimental obliterative bronchiolitis in rat tracheal allografts
15. Immunosuppressive therapies for the prevention and treatment of obliterative airway disease in heterotopic rat trachea allografts
16. Obliterative airway disease after heterotopic tracheal xenotransplantation
17. Antagonists of cyclic nucleotide phosphodiesterase (PDE) isoenzymes PDE3 and PDE4 suppress lymphoblastic response to HLA class II alloantigens: A potential novel approach to preventing allograft rejection?
18. The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo
19. Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro
20. Cyclic nucleotide phosphodiesterase isoenzyme activities in human alveolar macrophages
21. Suppression of lipopolysaccharideinduced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: Interaction with stimulants of adenylyl cyclase
22. Cyclic nucleotide phosphodiesterases from purified CD4+ and CD8+ T lymphocytes
23. Multiple high-affinity cAMP-phosphodiesterases in human T-lymphocytes
24. Progression of obliterative airway disease occurs despite the removal of immune reactivity by retransplantation
25. Chronic rejection: The result of uncontrolled remodeling of graft tissue by recipient mesenchymal cells? Data from two rodent models and the effects of immunosuppressive therapies
26. Chronic rejection: An update on the mechanism
27. Beta-adrenergic regulation of Cl- and HCO3-secretion by Clara cells
28. Beta-adrenoceptor, cAMP and airway smooth muscle relaxation: Challenges to the dogma
29. Role of cyclic adenosine monophosphate in the induction of endothelial barrier properties
30. The role of cyclic nucleotides in the cell cycle
31. The role of respiratory epithelium in a rat model of obliterative airway disease
32. Epithelial re-growth is associated with the inhibition of obliterative airway disease in orthotopic tracheal allografts in non-immunosuppressed rats
33. Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation
34. Does cyclosporine promote the secretion of transforming growth factor-beta 1 following pulmonary transplantation?
35. The role of transforming growth factor-beta in transplant rejection